These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26048514)

  • 21. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incretins or anti-incretins? A new model for the "entero-pancreatic axis".
    Kamvissi V; Salerno A; Bornstein SR; Mingrone G; Rubino F
    Horm Metab Res; 2015 Jan; 47(1):84-7. PubMed ID: 25388925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion].
    Dedov II; Melnichenko GA; Troshina EA; Ershova EV; Mazurina NV; Ogneva NA; Yashkov YI; Ilyin АV
    Ter Arkh; 2016; 88(10):9-18. PubMed ID: 27801414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA; Bergmann NC; Knop FK
    Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity associated with type 2 diabetes mellitus is linked to decreased PC1/3 mRNA expression in the Jejunum.
    Rohden F; Costa CS; Hammes TO; Margis R; Padoin AV; Mottin CC; Guaragna RM
    Obes Surg; 2014 Dec; 24(12):2075-81. PubMed ID: 24831459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.
    Novaes FS; Vasques AC; Pareja JC; Knop FK; Tura A; Chaim ÉA; Geloneze B
    J Clin Endocrinol Metab; 2015 May; 100(5):1984-8. PubMed ID: 25742514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
    Sigalet DL; Bawazir O; Martin GR; Wallace LE; Zaharko G; Miller A; Zubaidi A
    Dig Dis Sci; 2006 Sep; 51(9):1557-66. PubMed ID: 16927140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients.
    Kim MJ; Park HK; Byun DW; Suh KI; Hur KY
    Asian J Surg; 2014 Jul; 37(3):130-7. PubMed ID: 24210541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial.
    Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
    Nutrition; 2016 May; 32(5):553-9. PubMed ID: 26792024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes.
    Marathe CS; Rayner CK; Bound M; Checklin H; Standfield S; Wishart J; Lange K; Jones KL; Horowitz M
    Diabetes; 2014 Aug; 63(8):2668-75. PubMed ID: 24696447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
    Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
    J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.
    Roberge JN; Brubaker PL
    Endocrinology; 1993 Jul; 133(1):233-40. PubMed ID: 8319572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.
    Kuhre RE; Wewer Albrechtsen NJ; Hartmann B; Deacon CF; Holst JJ
    J Diabetes Complications; 2015 Apr; 29(3):445-50. PubMed ID: 25623632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells.
    Fujita Y; Chui JW; King DS; Zhang T; Seufert J; Pownall S; Cheung AT; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E648-57. PubMed ID: 18593849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individuals with type 2 diabetes have higher density of small intestinal neurotensin-expressing cells.
    Ferreira FP; Pereira SS; Costa MM; Guimarães M; Albrechtsen NJW; Holst JJ; Nora M; Monteiro MP
    Mol Cell Biochem; 2023 Dec; 478(12):2779-2787. PubMed ID: 36920577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
    Hira T; Koga T; Sasaki K; Hara H
    Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.